BACKGROUND Severe mental illness is responsible for a significant proportion of burden of diseases in Iranian population. People with severe mental illnesses are more likely to have high rates of non-attendance at follow-up visits, and lack of an active follow-up system, particularly in the country's urban areas that has resulted in the revolving door phenomenon of rehospitalizations. Therefore...

in december 2015, the world health organization (who) published the first ever report on the estimates of the global burden of foodborne diseases, which included diseases related to chemical exposures in foods such as peanut allergy. in the report, the burden of disease related to peanut allergies was measured for the european, american and west pacific regions. the report showed that unlike ot...

abstract level of groundwater is decreased which is mainly because, withdrawal of groundwater is increased, because of lack of right management. economics of rural based farming and farming is dependent of water so decreasing of groundwater effects social welfare. in this study decrease of welfare measure by reason of reduction of groundwater level considered. this study investigated the impact...

The U.S. Department of Agriculture Food Safety Inspection Service is responsible for ensuring the safety of meat, poultry, and egg products consumed in the United States. Here we describe a risk assessment method that provides quantitative criteria for decision makers tasked with developing food safety policies. To demonstrate the utility of this method, we apply it to a hypothetical case study...

Robert Berenson and colleagues caution that the patient-centered medical home (PCMH) faces many challenges. Its successful adoption will depend on its being precisely defined and demonstration that it is cost saving and scalable across varied clinical settings. Until these issues are addressed in current and upcoming pilot programs, caution about the PCMH's role in the care of people with chron...

Dr David Hamilton (http://www.nzma.org.nz/journal/118-1227/1774) accurately describes the clinical benefits of temozolomide and PHARMAC’s consideration of funding; and how this relates to what price to pay to prolong survival in incurable illnesses. We update progress with the funding of temozolomide, and agree there are dilemmas around the funding of high-cost medicines that give definite if l...